ArticleMedicina (Kaunas, Lithuania)2026

Cardio-Vasculo-Renal Benefits of SGLT2 Inhibitors in Heart Failure: A Retrospective Study from a Lower-Resource Tertiary Center.

Olivia-Maria Bodea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.